Caveolin 3 Antikörper (N-Term)
-
- Target Alle Caveolin 3 (CAV3) Antikörper anzeigen
- Caveolin 3 (CAV3)
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus, Ratte, Schwein
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Caveolin 3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Verwendungszweck
- CAV3
- Sequenz
- EHTDLEAQIV KDIH
- Spezifität
- Reported variants represent identical protein (NP_001225.1, NP_203123.1).
- Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Schwein, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence EHTDLEAQIVKDIH-C, from the N Terminus of the protein sequence according to NP_203123.1.
- Isotyp
- IgG
- Top Product
- Discover our top product CAV3 Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: In paraffin embedded Human Skeletal Muscle shows peripheral staining of fibres. Recommended concentration, 3-5 μg/mL.
Western Blot: Approx 23 kDa band observed in Human, Mouse and Rat Heart lysates and approx. 20 kDa in Pig Heart and Skeletal Muscle lysates (calculated MW of 17.3 kDa according to Human NP_203123.1,17.4 kDa according to Mouse NP_031643.1, Rat NP_062028.1 and
Peptide ELISA: antibody detection limit dilution 1:4000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- Caveolin 3 (CAV3)
- Andere Bezeichnung
- CAV3 (CAV3 Produkte)
- Synonyme
- LGMD1C antikoerper, LQT9 antikoerper, VIP-21 antikoerper, VIP21 antikoerper, AI385751 antikoerper, Cav-3 antikoerper, M-cav antikoerper, caveolin-3 antikoerper, im:6902906 antikoerper, zgc:109710 antikoerper, LOC733765 antikoerper, CAV3 antikoerper, cav3 antikoerper, caveolin 3 antikoerper, caveolin-3 antikoerper, CAV3 antikoerper, Cav3 antikoerper, cav3 antikoerper, LOC733765 antikoerper, cav-3 antikoerper
- Hintergrund
- CAV3, caveolin 3, LGMD1C, LQT9, MGC126100, MGC126101, MGC126129, VIP-21, VIP21, M-caveolin
- Gen-ID
- 859, 12391, 29161
- NCBI Accession
- NP_203123
- Pathways
- Carbohydrate Homeostasis, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Negative Regulation of Transporter Activity
-